NEW YORK, Sept 25 – Genzyme Molecular Oncology (Nasdaq: GZMO) said Monday it had licensed its gene expression database, SAGE, to Celera Genomics (NYSE: CRA) for distribution through the Celera Discovery System on a revenue sharing basis.

The SAGE database includes information on over 2.5 million gene sequences from cancerous and healthy tissues. Genzyme of Farmingham, Mass., will continue to provide Celera with additional SAGE data as the database expands.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.